new version becomes effective and is distributed to sites. The previous version should be marked “Superseded,” along with:

• Deactivation date
• Reason for supersession
• Linked document references

For SOPs defining these transitions, refer to PharmaValidation.in.

Step 2: Best Practices for Archiving Superseded Protocols

Effective archiving depends on both process control and system integrity. Follow these practices:

• Store in a validated eTMF system: Ensure document metadata (version, date, status) is preserved.
• Restrict user access: Limit editing rights to prevent accidental modifications of archived versions.
• Use clear file naming conventions: e.g., “Protocol_Version_2.0_Superseded_2024-06-01”.
• Maintain digital signatures and approval records: Ensure they’re included in the archived PDF.
• Log distribution dates and acknowledgments: Track when sites transitioned from one version to the next.

CRAs should confirm that only the current version is present in active site binders, while older versions are archived per SOP. For audit checklist examples, explore ClinicalStudies.in.

Step 3: Retention Timelines for Archived Protocols

Retention requirements for superseded protocols are defined by ICH GCP and local regulatory authorities. Key considerations include:

• Minimum Retention: ICH E6(R2) recommends keeping trial-related documents for at least 2 years after the last marketing application approval.
• Longer Requirements: Local regulations may extend this period (e.g., 25 years in some EU countries).
• Site-Specific Policies: Sponsors must ensure that sites follow the same retention schedule, especially for paper binders.

Document retention should be defined in your SOPs and monitored through Clinical Quality Assurance (CQA) teams to ensure consistency.

Step 4: Metadata and Audit Trail in Archival Systems

Proper archival doesn’t just mean storing a PDF file — it means preserving metadata and audit history. An effective archiving solution must track:

• Who archived the document
• Timestamp of archival
• Document status (e.g., Superseded, Archived, Obsolete)
• Change control reference numbers (if applicable)
• Associated documents (e.g., amendment memos, site letters)

Systems like Veeva Vault and MasterControl offer metadata and audit trail visibility. When using spreadsheets or manual trackers, ensure data integrity with regular reconciliations.

Step 5: Common Inspection Findings Related to Archiving

Regulatory agencies frequently issue findings related to improper or missing archival procedures. Examples include:

• Superseded protocols still present in active investigator site files
• Archived versions lacking metadata or approval history
• No documented SOP defining protocol archiving
• Archived copies without version history tables

A 2023 WHO audit report identified that over 35% of sponsor inspections had at least one major finding related to document control or archival inconsistencies.

Step 6: Real-World Case Study — Automated Archiving Implementation

A mid-sized oncology CRO integrated its eTMF with CTMS to automate archiving of superseded documents. When a new protocol was uploaded and approved, the system:

• Flagged the previous version as “Superseded”
• Archived it with full metadata and audit history
• Locked it from editing and restricted user visibility
• Triggered a CRA site update checklist

During a subsequent EMA inspection, the sponsor presented a full protocol lifecycle log. The inspector complimented the sponsor’s traceability and archiving control as a best practice.

Conclusion: Archiving Is a Core Part of Version Control Compliance

Proper archiving of superseded protocol versions is more than a clerical task — it’s a critical regulatory requirement. Organizations must document and enforce SOPs for version lifecycle, train teams on archive procedures, and utilize systems that support metadata and audit logs.

For implementation tools, secure archival workflows, and SOP templates, explore resources at PharmaValidation.in and PharmaRegulatory.in.